BMO Capital Upgrades Edwards Lifesciences (EW) to Outperform
Tweet
Share
E-mailGet Alerts EW Hot Sheet
Price: $92.45 -1.29%
Rating Summary:
31 Buy, 14 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 16 | New: 6
Rating Summary:
31 Buy, 14 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 16 | New: 6
Join SI Premium – FREE
BMO Capital upgraded Edwards Lifesciences (NYSE: EW) from Market Perform to Outperform with a price target of $158.00.
For an analyst ratings summary and ratings history on Edwards Lifesciences click here. For more ratings news on Edwards Lifesciences click here.
Shares of Edwards Lifesciences closed at $132.91 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Northland Upgrades Similarweb Ltd (SMWB) to Outperform
- Deutsche Bank Upgrades ACS Actividades de Construccion y Servicios SA (ACS:SM) (ACSAY) to Buy
- JPMorgan Upgrades Umicore SA (UMI:BB) (UMICY) to Overweight
Create E-mail Alert Related Categories
UpgradesRelated Entities
BMO CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
